NO872463D0 - Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning. - Google Patents

Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.

Info

Publication number
NO872463D0
NO872463D0 NO872463A NO872463A NO872463D0 NO 872463 D0 NO872463 D0 NO 872463D0 NO 872463 A NO872463 A NO 872463A NO 872463 A NO872463 A NO 872463A NO 872463 D0 NO872463 D0 NO 872463D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
antihypertensive effect
dihydropyridine derivatives
dihydropyridine
Prior art date
Application number
NO872463A
Other languages
English (en)
Other versions
NO872463L (no
Inventor
Gilles Genain
Original Assignee
Syntex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Lab filed Critical Syntex Lab
Publication of NO872463D0 publication Critical patent/NO872463D0/no
Publication of NO872463L publication Critical patent/NO872463L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO872463A 1986-06-13 1987-06-12 Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning. NO872463L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,264 US4761420A (en) 1986-06-13 1986-06-13 Antihypertensive dihydropyridine derivatives

Publications (2)

Publication Number Publication Date
NO872463D0 true NO872463D0 (no) 1987-06-12
NO872463L NO872463L (no) 1987-12-14

Family

ID=25363361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872463A NO872463L (no) 1986-06-13 1987-06-12 Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.

Country Status (13)

Country Link
US (1) US4761420A (no)
EP (1) EP0249245A3 (no)
JP (1) JPS632977A (no)
KR (1) KR880000394A (no)
AU (1) AU7416087A (no)
DK (1) DK300887A (no)
FI (1) FI872634A (no)
HU (1) HUT44503A (no)
IL (1) IL82860A0 (no)
NO (1) NO872463L (no)
PL (1) PL266231A1 (no)
PT (1) PT85075A (no)
ZA (1) ZA874257B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
HUT48461A (en) * 1987-12-11 1989-06-28 Syntex Lab Process for producing pharmaceutical compositions containing 1,4-dihydropyridine derivatives
DE3801717C1 (no) * 1988-01-21 1989-05-24 Alter S.A., Madrid, Es
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EP0824115A1 (en) * 1996-08-13 1998-02-18 Bp Chemicals S.N.C. Polymerisation process
WO2009012562A1 (en) 2007-07-20 2009-01-29 Therma Blade Inc. Ice skate blade and blade heating arrangement
US7866673B2 (en) * 2007-07-20 2011-01-11 Therma Blade Hockey Corp. Heating arrangement for ice skate blades
US7866674B2 (en) * 2007-09-07 2011-01-11 Thermablade Hockey Corp. Electrically heated ice skates
CN102655095B (zh) 2011-06-01 2014-10-15 京东方科技集团股份有限公司 薄膜晶体管及阵列基板的制造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
EP0164247B1 (en) * 1984-06-07 1989-01-11 Pfizer Limited Dihydropyridines
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
US4595690A (en) * 1985-02-11 1986-06-17 Syntex (U.S.A.) Inc. Antihypertensive dihydropyridine derivatives

Also Published As

Publication number Publication date
KR880000394A (ko) 1988-03-25
IL82860A0 (en) 1987-12-20
US4761420A (en) 1988-08-02
EP0249245A2 (en) 1987-12-16
FI872634A0 (fi) 1987-06-12
PT85075A (en) 1987-07-01
DK300887D0 (da) 1987-06-12
EP0249245A3 (en) 1988-08-10
JPS632977A (ja) 1988-01-07
DK300887A (da) 1987-12-14
HUT44503A (en) 1988-03-28
FI872634A (fi) 1987-12-14
NO872463L (no) 1987-12-14
ZA874257B (en) 1989-01-25
AU7416087A (en) 1987-12-17
PL266231A1 (en) 1988-09-01

Similar Documents

Publication Publication Date Title
NO870579D0 (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO873205L (no) Fremgangsmaate for fremstilling av carbapenemforbindelser i krystallinsk form.
NO862661D0 (no) Fremgangsmaate for fremstilling av n-aralkylpiperidinmethanolderivater.
NO170216C (no) Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
DK404187A (da) Fremgangsmaade til fremstilling af thiazolderivater
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO862861D0 (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO872463D0 (no) Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.
NO163453C (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO884900L (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO870128D0 (no) Fremgangsmaate for fremstilling av fluorerte diaminoalkyn-derivater.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO872683D0 (no) Fremgangsmaate for fremstilling av difenylazometinderivater
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO873019D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater.
ES556220A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas
NO168627C (no) Fremgangsmaate for fremstilling av hurtig-frigjoerende dihydropyridin-preparat.